Leadership Momentum Fingerpaint's 2026 leadership promotions across Marketing Services, Fingerpaint Marketing, and technology leadership signal a deliberate expansion into integrated marketing and product enabled services. This creates cross-sell opportunities for large pharma and biotech brands seeking end to end campaigns and digital product development.

Market Access Expansion The launch of a commercial support program to accelerate patient access for a rare brain cancer therapy demonstrates a market access and patient support capability. This enables cross selling to other therapies with payer and access focused campaigns.

Scale and Recognition With substantial revenue scale and Manny Awards finalist recognition, Fingerpaint is positioned to win enterprise level pharma clients needing integrated services across creative, digital, and market access at scale.

Tech Enabled Marketing A Chief Technology and Product Officer appointment alongside a tech forward stack indicates strong capabilities in marketing technology, automation, and data driven campaigns ideal for complex life sciences programs.

Strategic Growth Capacity Headquartered in New Jersey with a sizable workforce, Fingerpaint has geographic reach and cross functional talent to execute large multi channel campaigns for national brands and expand into new regions and therapeutic areas.